Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP-01 for Cannabis Withdrawal Symptoms in Cannabis Use Disorder
NCT07644052Phase 3Recruiting
- Sponsor
- PleoPharma, Inc.
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of PP-01 in cannabis withdrawal (3 arms), sponsored by PleoPharma, Inc. Primary endpoints: Area Under the Curve of the Cannabis Symptom Checklist-Withdrawal and Area Under the Curve of the Cannabis Symptom Checklist-Withdrawal for Rebound. Started Jun 2026; status: recruiting.
02
Drugs
PP-01
03
Conditions
cannabis withdrawal
Beyond the preview
Go deeper on NCT07644052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07644052.